Search Results - "Handshoe, John"

Routine Screening for Triple-Negative Adenocarcinoma (TNA) Lung Cancer Patients: A New Hope for a Poor-Prognosis Population by Handshoe, John M., Skelton, Rachel L., Lawrence, Kasey D., Chatfield, Lindsay E., Morris, Stephan W., Hout, David R., Schweitzer, Brock L.

Get full text

A prospective study to compare qPCR to IHC and FISH for the detection of anaplastic lymphoma kinase (ALK) fusions in FFPE specimens from NSCLC patients ( PCRTALK ) by Hout, David Richard, Handshoe, John, Schweitzer, Brock, Morris, Stephan Wade, Karsan, Aly, Daudt, Helena, Saltman, David

“…Abstract only…”
Get full text

Novel qPCR screen for efficient and reliable identification of RET fusion-positive non-small cell lung cancer by Schweitzer, Brock Lloyd, Smith, Rebecca B, Skelton, Rachel, Vincent, Ryan, McMahon, Frank, Handshoe, John, Morris, Stephan Wade, Hout, David Richard

“…Abstract only…”
Get full text

Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer by Hout, David R, Schweitzer, Brock L, Lawrence, Kasey, Morris, Stephan W, Tucker, Tracy, Mazzola, Rosetta, Skelton, Rachel, McMahon, Frank, Handshoe, John, Lesperance, Mary, Karsan, Aly, Saltman, David L

“…Patients with lung cancers harboring an activating anaplastic lymphoma kinase ( ) rearrangement respond favorably to ALK inhibitor therapy. Fluorescence in…”
Get full text

Abstract 1930: The unknown piece of the pie: Molecular markers in triple-negative lung cancer by Schweitzer, Brock L., Lawrence, Kasey D., Handshoe, John, Skelton, Rachel, Chatfield, Lindsay, Xue, Liquan, Morris, Stephan W., Hout, David R.

“…Abstract Lung cancer is the main cause of cancer mortality worldwide. Approximately ∼80% of lung cancer cases are non-small cell lung cancer (NSCLC) in type…”
Get full text

Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease by Lawrence, Kasey, Berry, Brian, Handshoe, John, Hout, David, Mazzola, Rosetta, Morris, Stephan W, Saltman, David L

“…The anaplastic lymphoma kinase (ALK) gene encodes a receptor tyrosine kinase, which was first identified as the fusion partner of the nucleophosmin (NPM1) gene…”
Get full text

Abstract 2220: Insight ALK ScreenTM, a highly sensitive and specific RT-qPCR first-line screening assay for comprehensive detection of all oncogenic anaplastic lymphoma kinase (ALK) fusions: clinical validation by Hout, David, Xue, Liquan, Choppa, Paul, Handshoe, John, Bloom, Kenneth, Ross, Douglas, Nickols, Josh, Morris, Stephan W.

“…Abstract More than 15 different ALK fusions (e.g., CLTC-ALK, multiple EML4-ALK variants, KIF5B-ALK, NPM-ALK, RanBP2-ALK, TFG-ALK, TPM4-ALK, others) cause…”
Get full text